SmileDirectClub Falls 5% Despite A Narrower 3Q Loss
BioNTech, Fosun Pharma Get Green Light To Start Covid-19 Vaccine Trial In China
UK Citizens 'Could Be Banned From Going Into Work' Without Proof Of COVID Vaccination
Phillips 66 or Valero Energy: Which Stock Is The Better Energy Play?
Israel In Talks To Buy Russia's COVID Vaccine
There Has Been A Sudden, "Huge" Drop In COVID-Testing In The US
UK eyes access deal as Moderna’s COVID-19 shot hits the mark
Inovio Gets FDA Go-Ahead To Initiate Covid-19 Vaccine Trial; Shares Rise 11%
SMEs are a bedrock of the British economy – so why is it so hard to get northern enterprises funded?
Key Events This Week: Data Deluge And Fed Speaker Bonanza
S&P Futures Surge, Nasdaq, Treasuries Plunge On "Game-Changer" Moderna Covid Vaccine
Agilent’s Diagnostic Tool Wins FDA Nod For Use In Breast Cancer Patients
Why there's no COVID in this year's Christmas ads
Harbr raises $38.5M to help enterprises exchange and share big data troves securely
More COVID-19 Restrictions Expected Across US, Europe As World Awaits Latest Vaccine Update: Live Updates
Good macro data from Asia is giving wings to the main global indices
J&J begins trial of two-dose COVID-19 vaccine regimen
Macro Briefing: 16 November 2020
UK Health Study Found 26,000 "Extra" Non-COVID Deaths At Home Amid Lockdowns
Germany Wants To Avoid "Yo-Yo Shutdown" Of Economy With 4-5 Months Of 'Severe' Lockdown
Guido Rasi steps down, handing the running of EMA to Emer Cooke
Weekly Market Outlook: Central banks, OPEC and Brexit take centre stage
J&J Kicks Off Two-Dose Phase 3 Covid-19 Trial In UK; Street Bullish
Covid-19 transmission risk very low in elite sports events, says UK doctor
A Closer Look at the Price Action
Bonhoeffer Fund 3Q20 Commentary – Case Study: MMA Capital (MMAC)
Why A COVID Vaccine Won't Invigorate The Oil Market
Prospect of a Vaccine Signals a New Game is Afoot
Week Ahead – Focus stays on COVID
Tactical asset allocation — November 2020